Parkinson’s Disease and Movement Disorders Center of Silicon Valley

Dr. Salima Brillman

Dr. Salima Brillman is a board certified neurologist with a fellowship in movement disorders, which include Parkinson’s Disease, Atypical Parkinsonism, Drug Induced Parkinsonism, Essential Tremor, Dystonia, Lewy Body Dementia and other Neurodegenerative disorders. Upon completion of her fellowship in 2006, she was a pioneer in the development of the only DBS program in North Dakota where she also was on the faculty at UND. In Florida, she became involved in clinical trials, served on the faculty at FIU and continued her passion for patient care. In 2015, she and her family moved back to her native California, where she was the Director of the Clinical Care Program at the Parkinson’s Institute and Clinical Center.

Dr. Brillman has extensive experience in diagnosing and treating all forms of movement disorders and is proficient in DBS, Duopa and Neurotoxin therapies. She is not only interested in the motor aspects of movement disorders, but the vast non-motor elements that accompany each disease state and recognizes the importance of following those as well. She is happy to have had the privilege over the past decade to give lectures to colleagues and patients regarding movement disorders.

Since the completion of her fellowship in 2006, there have been improvements as well as new symptomatic treatments for several movement disorders, in particular, Parkinson’s Disease. Dr. Brillman has not only been an active participant in this widespread proliferation of improvements in PD treatments, but also serves as an integral resource and advocate for patients and their families.

Concierge Medicine

Dr. Brillman identifies the fact that no two people have exactly the same disease states, therefore will not have identical therapeutic regimens. She emphasizes the importance of taking the time to meet the specific needs of each person and their family.

Access to your Doctor

Individualized Care in the Home or Office

Continuity of care

The Newest Parkinson's Disease Treatments and Access to Clinical Trials

Coordinated Care with Other Providers